<!DOCTYPE html>
<html lang="en-us">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>Posts | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>Posts</span>
        <span>2024-04-06</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38581289/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240406181050&amp;v=2.18.0.post9&#43;e462414">Learnings from phosphatidylinositol 3-kinase inhibitors in lymphoma-Moving to a model where less can be more</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38581289-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240406181050-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The role of Pi3K inhibitors in lymphoma is diminishing due to the adverse results from trials in indolent lymphoma, but is a one-size-fits-all approach to drug development penalising some lymphoma subtypes and the newer generation of Pi3K inhibitors? The report by Soumerai et al. of zandelisib with zanubrutinib in follicular and mantle cell lymphoma is an important addition to the data. Commentary on: Soumerai et al. Safety and efficacy of zandelisib plus zanubrutinib in previously &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38581389/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240406181050&amp;v=2.18.0.post9&#43;e462414">Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights from the EMPACT-MI Trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38581389-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240406181050-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In patients after acute myocardial infarction with left ventricular dysfunction or congestion, empagliflozin reduced the risk of heart &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38581410/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240406181050&amp;v=2.18.0.post9&#43;e462414">Adverse Events Reporting in Digital Interventions Evaluations for Psychosis: A Systematic Literature Search and Individual Level Content Analysis of Adverse Event Reports</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38581410-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240406181050-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The results support the safety of DHIs, but AEs must be routinely monitored and evaluated according to best practice. Individual-level analyses of AEs have merit to understand safety in this emerging field. Recommendations for best practice reporting in future studies are &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38581422/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240406181011&amp;v=2.18.0.post9&#43;e462414">HyGAnno: hybrid graph neural network-based cell type annotation for single-cell ATAC sequencing data</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38581422-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240406181011-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Reliable cell type annotations are crucial for investigating cellular heterogeneity in single-cell omics data. Although various computational approaches have been proposed for single-cell RNA sequencing (scRNA-seq) annotation, high-quality cell labels are still lacking in single-cell sequencing assay for transposase-accessible chromatin (scATAC-seq) data, because of extreme sparsity and inconsistent chromatin accessibility between datasets. Here, we present a novel automated cell &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38581519/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240406181050&amp;v=2.18.0.post9&#43;e462414">Cardio-renovascular health: The new guidelines</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38581519-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240406181050-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O8so5fhki">Ramyåœ¨HBO Maxä¸Šä¸ä¹…å‰æ’­å‡ºäº†ä¸€ä¸ªstandupï¼ˆè„±å£ç§€ï¼‰ï¼Œé‡Œé¢è¯´ä»–æœ€æ€•çš„äººå°±æ˜¯é‚£äº›åœ¨å®¶é‡ŒæŒ‚ä¸€å¼ ç¾å›½å›½æ——çš„ã€‚æ„ŸåŒèº«å—ã€‚åˆ«è¯´å®¶é‡Œé¢æŒ‚ä¸€å¼ ç¾å›½å›½æ——äº†ï¼Œå°±æ˜¯é‚£äº›åœ¨è½¦ä¸Š...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o8so5fhki/">
    
    
    
    
    
      
    
    Ramyåœ¨HBO Maxä¸Šä¸ä¹…å‰æ’­å‡ºäº†ä¸€ä¸ªstandupï¼ˆè„±å£ç§€ï¼‰ï¼Œé‡Œé¢è¯´ä»–æœ€æ€•çš„äººå°±æ˜¯é‚£äº›åœ¨å®¶é‡ŒæŒ‚ä¸€å¼ ç¾å›½å›½æ——çš„ã€‚æ„ŸåŒèº«å—ã€‚åˆ«è¯´å®¶é‡Œé¢æŒ‚ä¸€å¼ ç¾å›½å›½æ——äº†ï¼Œå°±æ˜¯é‚£äº›åœ¨è½¦ä¸Šè´´ä¸ªç¾å›½å›½æ——çš„ä¹ŸæŒºå¯æ€•çš„ï¼Œå°¤å…¶æ˜¯pickupï¼Œå¼„ä¸å¥½toolboxé‡Œå°±æ˜¯ä¸€æŠŠAR-15ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O8ukjmojV">æ¥ä¸€æ¯æ¡‘è‘šè–„è·æ‹¿é“ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o8ukjmojv/">
    
    
    
    
    
      
    
    æ¥ä¸€æ¯æ¡‘è‘šè–„è·æ‹¿é“ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8uAKly9w">é•¿å¤§åæˆ‘æˆä¸ºäº†ä½ </a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8uakly9w/">
    
    
    
    
    
      
    
    é•¿å¤§åæˆ‘æˆä¸ºäº†ä½   &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8vDBihho">è½¬å‘å¾®åš - è½¬å‘ @å±±ä¸‹ç¾æœˆæ•™ä¼š:&amp;ensp;å±±ä¸‹ç¾æœˆ ä»Šå¤©4æœˆ6æ—¥(åœŸ)23:00ï½ã€NHKã€ŒVenue101ã€ä¸­ä¹ƒæœ¨å‚46å°†ä¼šå‡ºæ¼”ğŸª©âœ¨ä»Šå¤©å°†ä¼šç©¿ç€è¥¿éƒ¨é£æ ¼çš„æ–°æœè£…è¿›è¡Œè¡¨æ¼”ï¼ğŸ¤...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8vdbihho/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å±±ä¸‹ç¾æœˆæ•™ä¼š<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å±±ä¸‹ç¾æœˆ<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->ä»Šå¤©4æœˆ6æ—¥(åœŸ)23:00ï½ã€NHKã€ŒVenue101ã€ä¸­ä¹ƒæœ¨å‚46å°†ä¼šå‡ºæ¼”ğŸª©âœ¨<!-- raw HTML omitted --><!-- raw HTML omitted -->ä»Šå¤©å°†ä¼šç©¿ç€è¥¿éƒ¨é£æ ¼çš„æ–°æœè£…è¿›è¡Œè¡¨æ¼”ï¼ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8wIMxwb3">è°å‘æ˜çš„é’‰è€™å­åˆ˜æµ·[ä¸¾è½¦] - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#shiorigram# .GEKIÃ—CINEã€å¤©å·æ˜Ÿã€ä»Šå¤©ä¸Šæ˜ äº†â€¦ï¼ï¼æˆ‘åˆæ¬¡æœ‰å¹¸å‚åŠ çš„ï¼Œå‰§å›¢â˜†æ–°æ„Ÿçº¿æ¡‘çš„èˆå°å‰§...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8wimxwb3/">
    
    
    
    
    
      
    
    è°å‘æ˜çš„é’‰è€™å­åˆ˜æµ·<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/">https://n.sinaimg.cn/photo/5213b46e/</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8yAr3SU4">ä¸çŸ¥é“åœ¨å¹²ä»€ä¹ˆäºæ˜¯è«åå…¶å¦™é€šå®µäº†ï¼ˆ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8yar3su4/">
    
    
    
    
    
      
    
    ä¸çŸ¥é“åœ¨å¹²ä»€ä¹ˆ<!-- raw HTML omitted -->äºæ˜¯è«åå…¶å¦™é€šå®µäº†ï¼ˆ  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O8shJvGws">å°±å°å­©å­å˜›ï¼æ¯«ç„¡é•å’Œæ„Ÿï¼[å“ˆå“ˆ][å“‡] - è½¬å‘ @ä¹Œå†¬å¾ˆæ€‚ä¸è¿›å‡»:&amp;ensp;via.Tiktok ä¹Œå†¬å¾ˆæ€‚ä¸è¿›å‡»çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o8shjvgws/">
    
    
    
    
    
      
    
    å°±å°å­©å­å˜›ï¼æ¯«ç„¡é•å’Œæ„Ÿï¼<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@ä¹Œå†¬å¾ˆæ€‚ä¸è¿›å‡»<!-- raw HTML omitted -->:â€‚via.Tiktok <!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O8skSDKti">è½‰ç™¼å¾®åš - è½¬å‘ @ä¹Œå†¬å¾ˆæ€‚ä¸è¿›å‡»:&amp;ensp;ç”Ÿç”°ç»˜æ¢¨èŠ± #ç”Ÿç”°ç»˜æ¢¨èŠ±# via.Tiktok ä¹Œå†¬å¾ˆæ€‚ä¸è¿›å‡»çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o8sksdkti/">
    
    
    
    
    
      
    
    è½‰ç™¼å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@ä¹Œå†¬å¾ˆæ€‚ä¸è¿›å‡»<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç”Ÿç”°ç»˜æ¢¨èŠ±<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%94%9F%E7%94%B0%E7%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%94%9F%E7%94%B0%E7%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O8tWmcM6i">åœ˜å¯µ - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#shiorigram# ä¸œäº¬ä¹Ÿå¥½å¤§é˜ªä¹Ÿå¥½èˆå°å·¦ä¾§å’Œå³ä¾§çš„åå°éƒ½å„æœ‰ä¸€ä¸ªæˆ‘çš„å›¢æ‰‡ç»™å¤§å®¶ç”¨â€¦å·¥ä½œäººå‘˜å’Œå…¶ä»–æ¼”å‘˜ä»¬éƒ½æ¥äº†å¤å·¡â€¦åœ£...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o8twmcm6i/">
    
    
    
    
    
      
    
    åœ˜å¯µ<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t">https://m.weibo.cn/search?containerid=231522type%3D1%26t</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O8wqSkuiJ">æ£‹æ‰‹æˆ˜é¹°â†è¿™ä¸ªå®¶ä¼™å•¥æ—¶å€™ç”Ÿæ—¥æ¥ç€ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o8wqskuij/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æ£‹æ‰‹æˆ˜é¹°<!-- raw HTML omitted --><!-- raw HTML omitted -->â†è¿™ä¸ªå®¶ä¼™å•¥æ—¶å€™ç”Ÿæ—¥æ¥ç€ï¼Ÿ  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O8wt24kov">å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šæ€ªç«¥ä¸¸ï¼šæœ¨è°·å®çš„ä¹˜èƒœè¿½å‡»â€”â€”æ—¥æœ¬å›´æ£‹ç™¾å¤§å¥ åŸºäºº005ã€‹ #å›´æ£‹# å›´æ£‹ æ€ªç«¥ä¸¸ï¼šæœ¨è°·å®çš„ä¹˜èƒœè¿½å‡»â€”â€”æ—¥æœ¬å›´æ£‹ç™¾å¤§å¥ åŸºäºº005 [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o8wt24kov/">
    
    
    
    
    
      
    
    å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šæ€ªç«¥ä¸¸ï¼šæœ¨è°·å®çš„ä¹˜èƒœè¿½å‡»â€”â€”æ—¥æœ¬å›´æ£‹ç™¾å¤§å¥ åŸºäºº005ã€‹ <!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O8wzoEIxg">å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€ŠèŠé‡è™ä¸¸æœç€â€œæ¯•ä¸šâ€å¤§æ­¥è¿ˆè¿›ã€‹ #å›´æ£‹# å›´æ£‹ èŠé‡è™ä¸¸æœç€â€œæ¯•ä¸šâ€å¤§æ­¥è¿ˆè¿› [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o8wzoeixg/">
    
    
    
    
    
      
    
    å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€ŠèŠé‡è™ä¸¸æœç€â€œæ¯•ä¸šâ€å¤§æ­¥è¿ˆè¿›ã€‹ <!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O8s1ubSQR">ä¹…ä¿å²ç»ªé‡Œ - è½¬å‘ @YodaChannel:&amp;ensp;ä¸ç”°ç¥å¸Œ #ä¸ç”°ç¥å¸Œ# 2024.04.05 11:48 YodaChannelçš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o8s1ubsqr/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@YodaChannel<!-- raw HTML omitted -->:â€‚&lt;a href=&ldquo;<a href="https://m.weibo.cn/p/index?extparam=%E4%B8%8E%E7%94%B0%E7%A5%90%E5%B8%8C&amp;amp;containerid=10080814f44">https://m.weibo.cn/p/index?extparam=%E4%B8%8E%E7%94%B0%E7%A5%90%E5%B8%8C&amp;amp;containerid=10080814f44</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O8svU7hbx">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.04.05 09:42(è¡¥)ã€Œå‘œå‘¼å‘¼ã€æ—©ä¸Šå¥½ã€œæ˜¨æ™šæ˜¯è¦åçœçš„ä¸€å¤œâ€¦åœ¨å®Œæˆå¿…é¡»è¦åšçš„äº‹æƒ…å‰å°±ç¡ç€äº†â€¦ç¡ç€äº†â€¦å¸Œæœ›ä»Šå¤©èƒ½å¼¥è¡¥è¿‡æ¥â€¦è¿™...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o8svu7hbx/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O8sx3ETgU">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# .GEKIÃ—CINEã€å¤©å·æ˜Ÿã€ä»Šå¤©ä¸Šæ˜ äº†â€¦ï¼ï¼æˆ‘åˆæ¬¡æœ‰å¹¸å‚åŠ çš„ï¼Œå‰§å›¢â˜†æ–°æ„Ÿçº¿æ¡‘çš„èˆå°å‰§ã€‚æ˜¯æˆ‘éš¾ä»¥å¿˜æ€€çš„ç»éªŒã€‚æˆ‘ä¹Ÿæ‰“ç®—åœ¨ç”µå½±é™¢ï¼Œå†æ¬¡æ„Ÿå—é‚£...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o8sx3etgu/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram# &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O8sxDhthc">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.04.06 13:09ã€Œæ¢¦æƒ³å’Œç°å®ã€æ—©ä¸Šå¥½ã€œå¿ƒé‡Œå¹³å’Œçš„æ—¥å­çœŸæ˜¯ç¾å¥½å‘¢ï½ç°åœ¨çš„å¿ƒæƒ…æ˜¯æƒ³å»æµ·è¾¹è¿™ä¹ˆè¯´çš„åŒæ—¶ï¼Œå¿…é¡»è¦åšçš„äº‹æƒ…å°±åœ¨æˆ‘çœ¼...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o8sxdhthc/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O8sxhdl62">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# ä¸œäº¬ä¹Ÿå¥½å¤§é˜ªä¹Ÿå¥½èˆå°å·¦ä¾§å’Œå³ä¾§çš„åå°éƒ½å„æœ‰ä¸€ä¸ªæˆ‘çš„å›¢æ‰‡ç»™å¤§å®¶ç”¨â€¦å·¥ä½œäººå‘˜å’Œå…¶ä»–æ¼”å‘˜ä»¬éƒ½æ¥äº†å¤å·¡â€¦åœ£å­æ¡‘å°±ç®—åœ¨ä¼‘æ¯å®¤ä¹Ÿä¸€ç›´éƒ½åœ¨ä½¿...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o8sxhdl62/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O8sxScQrA">ä¹…ä¿å²ç»ªé‡Œå¤©è™Ÿæ˜Ÿ é™¢çº¿å‘å¸ƒ åª’ä½“å›¾ æ›´æ–° [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o8sxscqra/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->å¤©è™Ÿæ˜Ÿ é™¢çº¿å‘å¸ƒ åª’ä½“å›¾ æ›´æ–° <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1ho">https://tvax3.sinaimg.cn/large/006z6nxLgy1ho</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O8sxwDwuZ">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.04.05 22:06(è¡¥)ã€Œæ— é¢˜ã€è¿™å‘¨æ„Ÿè§‰ä¸çŸ¥æ€çš„ï¼Œå‘¨ä¸‰å¹¿æ’­å‘¨å››Nogiobiå‘¨äº”èˆå°è§é¢ä¼šå‘¨å…­éŸ³ä¹èŠ‚ç›®æ¯å¤©éƒ½èƒ½å¤Ÿä»¥ä¸åŒçš„è‡ªå·±ï¼Œè§¦åŠåˆ°...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o8sxwdwuz/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%25B">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38576222/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">Biological Variation Estimates for Plasma Copeptin and Clinical Implications</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38576222-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The availability of BV data allows for refined APS and associated II, and RCVs applicable as aids in the serial monitoring of patients with specific diseases such as heart failure. The BV estimates are only applicable in subjects who abstained from oral intake due to the rapid and marked effects of fluids on copeptin &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38576796/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">Is there an immunological cross-reactivity of antibodies to the myelin oligodendrocyte glycoprotein and coronaviruses?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38576796-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Recent reports indicated that myelin oligodendrocyte glycoprotein antibody-associated disease might be a rare complication after severe acute respiratory syndrome coronavirus 2 infection or vaccination. It is unclear whether this is an unspecific sequel of infection or vaccination or caused by possible immunological cross-reactivity of severe acute respiratory syndrome coronavirus 2 proteins and myelin oligodendrocyte glycoprotein. The aim of this study was therefore to elucidate whether &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38577107/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">Disruption of CD47-SIRPÎ± signaling restores inflammatory function in tumor-associated myeloid-derived suppressor cells</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38577107-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Myeloid-derived suppressor cells (MDSCs) are a heterogeneous immune population with diverse immunosuppressive functions in solid tumors. Here, we explored the role of the tumor microenvironment in regulating MDSC differentiation and immunosuppressive properties via signal-regulatory protein alpha (SIRPÎ±)/CD47 signaling. In a murine melanoma model, we observed progressive increases in monocytic MDSCs and monocyte-derived dendritic cells that exhibited potent T cell-suppressive capabilities. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38577494/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240405180744&amp;v=2.18.0.post9&#43;e462414">Resolution of metastatic neck nodes associated with a periauricular cutaneous squamous cell carcinoma after intranodal injection of talimogene laherparepvec</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38577494-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240405180744-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38577494/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240406181021&amp;v=2.18.0.post9&#43;e462414">Resolution of metastatic neck nodes associated with a periauricular cutaneous squamous cell carcinoma after intranodal injection of talimogene laherparepvec</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38577494-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240406181021-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38577791/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">Exploring evolutionary trajectories in ovarian cancer patients by longitudinal analysis of ctDNA</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38577791-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: We demonstrate that tracing the temporal heterogeneity of ctDNA, even below exome scale resolution, deciphers evolutionary trajectories in ovarian cancer. Furthermore, we describe two evolutionary patterns that may help to identify relapse seeding clones for targeted &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38577801/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">Navigating data standards in public health: A brief report from a data-standards meeting</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38577801-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38577820/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38577820-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Human papillomavirus (HPV) proteins may elicit antibody responses in the process toward HPV-related malignancy. However, HPV seroepidemiology in noncervical HPV-related cancers remains poorly understood, particularly in populations with a high prevalence of human immunodeficiency virus (HIV). Using a glutathione S-transferase-based multiplex serology assay, antibodies against E6, E7 and L1 proteins of HPV16 and HPV18 were measured in sera of 535 cases of noncervical HPV-related cancers (anal &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38577925/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">[Retracted] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of antiâ€‘apoptotic proteins</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38577925-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Following the publication of the above article and a corrigendum that was published in October 2023 to address the issue of misplaced control Î²â€‘actin western blots comparing between Figs. 3 and 4A (doi: 10.3892/or.2023.8646), an attentive reader drew to the authors' attention that the first author had apparently made additional unreported corrections to the revised version of Fig. 4 presented in the corrigendum. Although these image discrepancies did not alter the study&rsquo;s primary &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38578306/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent MRI lesions after first-line treatment</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38578306-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Overall response and extent of lesions can function as surrogate parameters to predict outcomes in pediatric MB patients with persistent lesions after first-line therapy. Especially in case of solitary persistent medulloblastoma MRI lesion, additional therapy was not beneficial. Therefore, treatment response, extent/kind of residual lesions and further diagnostic information needs consideration for indication of additional treatments for persisting &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38578306/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240406181050&amp;v=2.18.0.post9&#43;e462414">Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent MRI lesions after first-line treatment</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38578306-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240406181050-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Overall response and extent of lesions can function as surrogate parameters to predict outcomes in pediatric MB patients with persistent lesions after first-line therapy. Especially in case of solitary persistent medulloblastoma MRI lesion, additional therapy was not beneficial. Therefore, treatment response, extent/kind of residual lesions and further diagnostic information needs consideration for indication of additional treatments for persisting &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38578500/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38578500-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38578500/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240406181050&amp;v=2.18.0.post9&#43;e462414">Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38578500-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240406181050-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38578535/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">&#34;The anxiety coming up to every scan-It destroyed me&#34;: A qualitative study of the lived experience of cytomegalovirus infection during pregnancy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38578535-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Serological diagnosis of maternal CMV infection during pregnancy can have severe and prolonged psychological impacts on parents, regardless of the pregnancy outcome. Improving healthcare professionals' knowledge and public awareness are essential before widespread serological screening can be responsibly introduced. Healthcare administrators that are considering implementing a prenatal screening program for secondary prevention of fetal CMV infection should pay attention to &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38578535/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240406181050&amp;v=2.18.0.post9&#43;e462414">&#34;The anxiety coming up to every scan-It destroyed me&#34;: A qualitative study of the lived experience of cytomegalovirus infection during pregnancy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38578535-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240406181050-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Serological diagnosis of maternal CMV infection during pregnancy can have severe and prolonged psychological impacts on parents, regardless of the pregnancy outcome. Improving healthcare professionals' knowledge and public awareness are essential before widespread serological screening can be responsibly introduced. Healthcare administrators that are considering implementing a prenatal screening program for secondary prevention of fetal CMV infection should pay attention to &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38578671/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">Attributes, Methods, and Frameworks Used to Evaluate Wearables and Their Companion mHealth Apps: Scoping Review</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38578671-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our scoping review identified the types and categories of wearable devices and mHealth apps, their frequency of use in studies, and their implementation in the medical context. In addition, we examined the usability evaluation of these technologies: methods, attributes, and frameworks. Within the array of available wearables and mHealth apps, health care providers encounter the challenge of selecting devices and companion apps that are effective, user-friendly, and compatible &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38578671/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240406181050&amp;v=2.18.0.post9&#43;e462414">Attributes, Methods, and Frameworks Used to Evaluate Wearables and Their Companion mHealth Apps: Scoping Review</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38578671-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240406181050-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our scoping review identified the types and categories of wearable devices and mHealth apps, their frequency of use in studies, and their implementation in the medical context. In addition, we examined the usability evaluation of these technologies: methods, attributes, and frameworks. Within the array of available wearables and mHealth apps, health care providers encounter the challenge of selecting devices and companion apps that are effective, user-friendly, and compatible &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38578780/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240406181050&amp;v=2.18.0.post9&#43;e462414">Disruption of the mast cell carboxypeptidase A3 gene does not attenuate airway inflammation and hyperresponsiveness in two mouse models of asthma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38578780-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240406181050-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Mast cells are effector cells known to contribute to allergic airway disease. When activated, mast cells release a broad spectrum of inflammatory mediators, including the mast cell-specific protease carboxypeptidase A3 (CPA3). The expression of CPA3 in the airway epithelium and lumen of asthma patients has been associated with a Th2-driven airway inflammation. However, the role of CPA3 in asthma is unclear and therefore, the aim of this study was to investigate the impact of CPA3 for &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38578871/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240406181050&amp;v=2.18.0.post9&#43;e462414">Cardiovascular-Kidney-Metabolic Syndrome: Association with Adverse Events After Major Noncardiac Surgery</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38578871-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240406181050-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The newly defined CKM syndrome is associated with increased morbidity and mortality after non-cardiac surgery. Thus, cardiovascular, renal, and metabolic disorders should be regarded in mutual context in this &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38578888/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240406181050&amp;v=2.18.0.post9&#43;e462414">Clusterization of Behavioral and Psychological Symptoms of Dementia as Assessed by Neuropsychiatric Inventory: A Case Against the Use of Principal Component Analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38578888-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240406181050-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: We recommend the thorough characterization of multivariate distributions before subjecting any dataset to Principal Component &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38579222/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240406181050&amp;v=2.18.0.post9&#43;e462414">Comment on &#34;Nuclear Excitation by Free Muon Capture&#34;</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38579222-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240406181050-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38579236/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240406181050&amp;v=2.18.0.post9&#43;e462414">Photoelectron Circular Dichroism in the Spin-Polarized Spectra of Chiral Molecules</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38579236-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240406181050-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We studied strong-field multiphoton ionization of 1-iodo-2-methylbutane enantiomers with 395 nm circularly polarized laser pulses experimentally and theoretically. For randomly oriented molecules, we observe spin polarization up to about 15%, which is independent of the molecular enantiomer. Our experimental findings are explained theoretically as an intricate interplay between three contributions from HOMO, HOMO-1, and HOMO-2, which are formed of 5p-electrons of the iodine atom. For &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38579284/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240406181030&amp;v=2.18.0.post9&#43;e462414">Wiskott-Aldrich Syndrome: A study on 577 patients defining the genotype as a predictive biomarker for disease severity</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38579284-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240406181030-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    WAS is a multifaceted monogenic disorder with a broad disease spectrum and variable disease severity and a variety of treatment options including allogeneic hematopoietic stem cell transplantation (HSCT) and gene therapy (GT). No reliable biomarker exists to predict disease course and outcome for individual patients. A total of 577 patients with a WAS variant from 26 countries and a median follow-up of 8.9 years (0.3-71.1), totaling 6118 patient-years, were included in this &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38579285/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240406181030&amp;v=2.18.0.post9&#43;e462414">Bone marrow niches for hematopoietic stem cells: Lifespan dynamics and adaptation to acute stress</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38579285-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240406181030-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Hematopoietic stem cells (HSCs) are instrumental for organismal survival as they are responsible for lifelong production of mature blood lineages in homeostasis and response to external stress. To fulfill their function, HSCs rely on reciprocal interactions with specialized tissue microenvironments, termed HSC niches. From embryonic development to advanced aging, HSCs transition through several hematopoietic organs where they are supported by distinct extrinsic cues. Here, we describe &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38579286/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240406181030&amp;v=2.18.0.post9&#43;e462414">Loss of stress sensor GADD45A promotes stem cell activity and ferroptosis resistance in LGR4/HOXA9-dependent AML</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38579286-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240406181030-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    The overall prognosis of acute myeloid leukemia (AML) remains dismal, largely due to the inability of current therapies to kill leukemia stem cells (LSCs) with intrinsic resistance. Loss of the stress sensor GADD45A is implicated in poor clinical outcomes but its role in LSCs and AML pathogenesis is unknown. Here we define GADD45A as a key downstream target of LGR4 oncogenic signaling and discover a regulatory role for GADD45A loss in promoting leukemia-initiating activity and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38579288/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240406181030&amp;v=2.18.0.post9&#43;e462414">IL-18-secreting multi-antigen targeting CAR T-cells eliminate antigen-low myeloma in an immunocompetent mouse model</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38579288-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240406181030-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Multiple myeloma is a plasma cell malignancy that is currently incurable with conventional therapies. Following the success of CD19-targeted chimeric antigen receptor (CAR) T-cells in leukemia and lymphoma, CAR T-cells targeting B-cell maturation antigen (BCMA) more recently demonstrated impressive activity in relapsed and refractory myeloma patients. However, BCMA-directed therapy can fail due to low expression of BCMA on myeloma cells, suggesting that novel approaches to better &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38579685/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240406181050&amp;v=2.18.0.post9&#43;e462414">NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells inÂ vitro and inÂ vivo</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38579685-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240406181050-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The YAP/Hippo pathway is an organ growth and size regulation rheostat safeguarding multiple tissue stem cell compartments. LATS kinases phosphorylate and thereby inactivate YAP, thus representing a potential direct drug target for promoting tissue regeneration. Here, we report the identification and characterization of the selective small-molecule LATS kinase inhibitor NIBR-LTSi. NIBR-LTSi activates YAP signaling, shows good oral bioavailability, and expands organoids derived from several &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38579727/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240406181050&amp;v=2.18.0.post9&#43;e462414">Receptor transfer between immune cells by autoantibody-enhanced, CD32-driven trogocytosis is hijacked by HIV-1 to infect resting CD4 TÂ cells</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38579727-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240406181050-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Immune cell phenotyping frequently detects lineage-unrelated receptors. Here, we report that surface receptors can be transferred from primary macrophages to CD4 T cells and identify the FcÎ³ receptor CD32 as driver and cargo of this trogocytotic transfer. Filamentous CD32^(+) nanoprotrusions deposit distinct plasma membrane patches onto target T cells. Transferred receptors confer cell migration and adhesion properties, and macrophage-derived membrane patches render resting CD4 T &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38579991/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240406181050&amp;v=2.18.0.post9&#43;e462414">Mst4, a novel cardiac STRIPAK complex associated kinase, regulates cardiomyocyte growth and survival and is upregulated in human cardiomyopathy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38579991-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240406181050-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Myocardial failure is associated with adverse remodeling which includes apoptotic loss of cardiomyocytes, hypertrophy as well as alterations in cell-cell contacts. Striatin-interacting phosphatase and kinase (STRIPAK) complexes and their kinase Mst4 have been linked to the development of different diseases. The role and targets of Mst4 in cardiomyocytes have not been investigated, yet. Multi tissue immunoblot experiments show highly enriched Mst4-expression in rodent hearts. Analyses of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38580340/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240406181050&amp;v=2.18.0.post9&#43;e462414">Incomplete sensorimotor paresis after upper abdominal surgery with TEA and spinal epidural lipomatosis: a case report</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38580340-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240406181050-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: So far, only two uncomplicated lumbar epidural catheter anesthesias have been described in patients who had a lumbar SEL. Epidural catheter anesthesia is a safe and effective method of pain control. But it is important to carefully identify and stratify patients with risk factors during the premedication visit. In patients who had kyphosis and thoracic localization of SEL, TEA may only be used after a risk-benefit &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38580343/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240406181050&amp;v=2.18.0.post9&#43;e462414">Impact of DMARD treatment and systemic inflammation on all-cause mortality in patients with rheumatoid arthritis and interstitial lung disease: a cohort study from the German RABBIT register</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38580343-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240406181050-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Inflammatory biomarkers and absence of DMARD treatment were associated with increased risk of mortality in patients with RA-ILD. Non-TNFi bDMARDs may confer enhanced therapeutic benefits in patients with &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38581019/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240406181050&amp;v=2.18.0.post9&#43;e462414">Mesenchymal stromal cell chondrogenesis under ALK1/2/3-specific BMP inhibition: a revision of the prohypertrophic signalling network concept</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38581019-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240406181050-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Overall, our data show that BMP-ALK1/2/3 inhibition cannot program mesenchymal stromal cells toward stable chondrogenesis. BMP-ALK1/2/3 signalling is no driver of hypertrophic MSC misdifferentiation and BMP receptor induction is not an adverse prohypertrophic side effect of TGF-Î² that leads to endochondral MSC misdifferentiation. Instead, the prohypertrophic network comprises misregulated PTHrP/hedgehog signalling and WNT activity, and a potential contribution &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38581034/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240406181050&amp;v=2.18.0.post9&#43;e462414">CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38581034-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240406181050-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    A novel methylation class, &ldquo;neuroepithelial tumor, with PLAGL1 fusion&rdquo; (NET-PLAGL1), has recently been described, based on epigenetic features, as a supratentorial pediatric brain tumor with recurrent histopathological features suggesting an ependymal differentiation. Because of the recent identification of this neoplastic entity, few histopathological, radiological and clinical data are available. Herein, we present a detailed series of nine cases of PLAGL1-fused supratentorial &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O8hWkzHD6">Stanfordæ–¯å¦ç¦å¤§å­¦Matthew Porteusç»„åœ¨Cell Stem Cellå‘è¡¨äº†ä¸€é¡¹é‡è¦çš„HIVæ²»æ„ˆç ”ç©¶ã€‚Matthew Porteusåœ¨åŒ»ç–—å’Œç§‘æŠ€é¢†åŸŸéå¸¸æœ‰åï¼Œä»–æ˜¯Stanfordæ¯•ä¸šçš„MD-PhDï¼Œç°...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o8hwkzhd6/">
    
    
    
    
    
      
    
    Stanfordæ–¯å¦ç¦å¤§å­¦Matthew Porteusç»„åœ¨Cell Stem Cellå‘è¡¨äº†ä¸€é¡¹é‡è¦çš„HIVæ²»æ„ˆç ”ç©¶ã€‚Matthew Porteusåœ¨åŒ»ç–—å’Œç§‘æŠ€é¢†åŸŸéå¸¸æœ‰åï¼Œä»–æ˜¯Stanfordæ¯•ä¸šçš„MD-PhDï¼Œç°åœ¨æ˜¯Stanford MD-PhDé¡¹ç›®ï¼ˆMSTPï¼‰å‰¯ä¸»ä»»ï¼Œå¹¶ä¸”æ˜¯CRISPR Therapeuticsçš„åˆ›å»ºè€…ä¹‹ä¸€ã€‚ä»–çš„ç ”ç©¶ç»„å‘è¡¨çš„è¿™é¡¹ç ”ç©¶æ˜¯ä¸€é¡¹é‡è¦çš„æ¢ç´¢æ€§HIVæ²»æ„ˆç ”ç©¶ï¼Œé€šè¿‡CRISPR-Cas9ç¼–è¾‘é€ è¡€å¹²ç»†èƒï¼ˆHSCsï¼‰CCR5æ¥æŠµå¾¡R5å’ŒX4å—œæ€§çš„HIV-1ï¼Œä½¿é€ è¡€å¹²ç»†èƒç§»æ¤ï¼ˆHCTï¼‰åHIVæ— æ³•æ„ŸæŸ“ç§»æ¤ç‰©ç»†èƒã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->ç›®å‰å…¨ä¸–ç•Œæœ‰5ä¾‹HIVæ²»æ„ˆç—…ä¾‹å…¨éƒ¨æ˜¯é€šè¿‡CCR5Î”32 HCTå®ç°çš„ï¼ˆ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg">https://h5.sinaimg</a>. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O8jDKix0j">Scienceå‘è¡¨äº†ä¸€ç¯‡è¯„è®ºæ–‡ç« å¼•ç”¨äº†IHME Chris Murrayæ•°æ®æŒ‡å‡ºï¼Œå…¨çƒå‡ºç”Ÿç‡æŒç»­ä¸‹é™ï¼Œå¯èƒ½å°†åœ¨2030å¹´æå‰å‡ºç°äººå£å¢é•¿æ‹ç‚¹ã€‚æŒ‰ç…§ä¼ ç»Ÿçš„äººå£å­¦ç†è®ºï¼ˆreplacement fe...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o8jdkix0j/">
    
    
    
    
    
      
    
    Scienceå‘è¡¨äº†ä¸€ç¯‡è¯„è®ºæ–‡ç« å¼•ç”¨äº†IHME Chris Murrayæ•°æ®æŒ‡å‡ºï¼Œå…¨çƒå‡ºç”Ÿç‡æŒç»­ä¸‹é™ï¼Œå¯èƒ½å°†åœ¨2030å¹´æå‰å‡ºç°äººå£å¢é•¿æ‹ç‚¹ã€‚æŒ‰ç…§ä¼ ç»Ÿçš„äººå£å­¦ç†è®ºï¼ˆreplacement fertility rateï¼‰ï¼šå¹³å‡æ¯ä¸ªå¦‡å¥³éœ€è¦ç”Ÿè‚²2.1ä¸ªå­å¥³ï¼ˆTFR=2.1ï¼‰æ‰èƒ½æŠµæ¶ˆäººå£æ­»äº¡ç‡ï¼Œä½¿æ€»äººå£ç¨³å®šã€‚TFRè¶…è¿‡2.1åˆ™ä¼šå‡ºç°äººå£å¢é•¿ï¼›å¦åˆ™äººå£ä¼šä¸‹é™ã€‚ä¹‹å‰çš„å¾ˆå¤šç ”ç©¶é¢„æµ‹ï¼Œ2056å¹´ä¹‹åï¼ŒTFRå°†å°äº2.1ï¼Œä¹‹åå…¨äººç±»ä¼šå‡ºç°äººå£ä¸‹é™ã€‚ä½†è¿™ç¯‡æ–‡ç« å¼•ç”¨çš„æ¨¡å‹æŒ‡å‡ºï¼Œ2030å¹´å…¨äººç±»å¯èƒ½å°±ä¼šå‡ºç°TFRå°äº2.1çš„æ‹ç‚¹ï¼Œè€ŒTFRå°äº2.1åï¼Œéšç€è€å¹´äººæ­»äº¡ï¼Œäººç±»å°†åœ¨2060å¹´å‡ºç°å…¨çƒäººå£ç»å¯¹æ•°é‡ä¸‹é™ã€‚&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/4a994b1dgy1hofzabmqpxj247n4dfe81.jpg%22">https://tvax1.sinaimg.cn/large/4a994b1dgy1hofzabmqpxj247n4dfe81.jpg&quot;</a> referrerpolicy=&ldquo;no-ref &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O8jdNkax4">Fred Hutchçš„Larry Coreyç»„ï¼ˆç½‘é¡µé“¾æ¥ï¼‰åœ¨JCIå‘è¡¨äº†ä¸€ç¯‡HIVæ²»æ„ˆç ”ç©¶è®ºæ–‡ï¼Œéå¸¸æœ‰æ„æ€ã€‚è¯¥ç ”ç©¶ç›´æ¥ç”¨è¡¨è¾¾anti-PD-1 CAR-Tè¯•å›¾æ²»æ„ˆHIVï¼Œä¹‹æ‰€ä»¥è§‰å¾—è¿™é¡¹ç ”ç©¶æœ‰æ„æ€...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o8jdnkax4/">
    
    
    
    
    
      
    
    Fred Hutchçš„Larry Coreyç»„ï¼ˆ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç½‘é¡µé“¾æ¥<!-- raw HTML omitted --><!-- raw HTML omitted -->ï¼‰åœ¨JCIå‘è¡¨äº†ä¸€ç¯‡HIVæ²»æ„ˆç ”ç©¶è®ºæ–‡ï¼Œéå¸¸æœ‰æ„æ€ã€‚è¯¥ç ”ç©¶ç›´æ¥ç”¨è¡¨è¾¾anti-PD-1 CAR-Tè¯•å›¾æ²»æ„ˆHIVï¼Œä¹‹æ‰€ä»¥è§‰å¾—è¿™é¡¹ç ”ç©¶æœ‰æ„æ€ï¼Œæ˜¯å› ä¸ºPD-1+ Tfhç»†èƒå¯èƒ½æ˜¯HIVå‚¨è—åº“ï¼ˆ&lt;a href=&ldquo;<a href="https://weibo.com/1251560221/4164">https://weibo.com/1251560221/4164</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O8i6D2NwB">å¿…èƒœå®¢çš„å’–å•¡è¿æ°´éƒ½ç®—ä¸ä¸Š[æ€’][æ€’][æ€’][æ€’][æ€’][æ€’][æ€’][æ€’]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o8i6d2nwb/">
    
    
    
    
    
      
    
    å¿…èƒœå®¢çš„å’–å•¡è¿æ°´éƒ½ç®—ä¸ä¸Š<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[æ€’]&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O8i6n6uPk">è¯´å¥å®è¯ï¼Œæœ¬æ·„åšäººä»Šå¹´åº”è¯¥èƒ½å»åƒä¸€æ¬¡æ·„åšçƒ§çƒ¤äº†[äºŒå“ˆ]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o8i6n6upk/">
    
    
    
    
    
      
    
    è¯´å¥å®è¯ï¼Œæœ¬æ·„åšäººä»Šå¹´åº”è¯¥èƒ½å»åƒä¸€æ¬¡æ·„åšçƒ§çƒ¤äº†<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8hCdmOHa">è½¬å‘å¾®åš - è½¬å‘ @å±±ä¸‹ç¾æœˆæ•™ä¼š:&amp;ensp;å±±ä¸‹ç¾æœˆ#å±±ä¸‹ç¾æœˆæ‰‹æœºåš# 240404.2ã€Œææ–™ã€ä¹‹åè¿˜å¼€äº†ä¼šå•¥çš„å“¦â€”å¿™ç¢Œäº†ä¹‹åç»çºªäººè¯´ ä½ æ˜¯ä¸æ˜¯è¿˜æ²¡åƒé¥­å°±ç»™äº†æˆ‘é¥­å›¢å’ŒçŒªè‚‰...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8hcdmoha/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å±±ä¸‹ç¾æœˆæ•™ä¼š<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å±±ä¸‹ç¾æœˆ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%25E">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8kWtCLYN">æ‘¸æ‘¸è‚šè‚š - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.seventeenjp_mag ins é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8kwtclyn/">
    
    
    
    
    
      
    
    æ‘¸æ‘¸è‚šè‚š<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.seventeenjp_mag ins &lt;a href=&ldquo;<a href="https://video.weibo.com/show?fid=1034:5019757385023526%22">https://video.weibo.com/show?fid=1034:5019757385023526&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8n4fbwVU">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œå¤©è™Ÿæ˜Ÿ é™¢çº¿å‘å¸ƒ åª’ä½“å›¾ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8n4fbwvu/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->å¤©è™Ÿæ˜Ÿ é™¢çº¿å‘å¸ƒ åª’ä½“å›¾ &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/006z6nxLgy1hog8rwl31lj30xc0m8t9k.jpg%22">https://tvax4.sinaimg.cn/large/006z6nxLgy1hog8rwl31lj30xc0m8t9k.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8n4hdpRq">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.Venue 101 å®˜X é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8n4hdprq/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.Venue 101 å®˜X <!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8n4qEz9B">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡ŒGEKIÃ—CINEã€å¤©è™Ÿæ˜Ÿã€ åˆæ—¥èˆå°ç›¸å…³è§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8n4qez9b/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->GEKIÃ—CINEã€å¤©è™Ÿæ˜Ÿã€ åˆæ—¥èˆå°ç›¸å…³è§†é¢‘ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8n7eqJBY">ä»Šå¤©ï¼ˆï¼Ÿå…¶å®æ˜¯æ˜¨å¤©äº†ï¼‰ä¹Ÿè¿‡å¾—å¾ˆå¼€å¿ƒï¼æˆ‘ç…çš„è›‹å§å§åŒ…çš„é”…è´´é…ç™½è±¡çš„ç«é¸¡é¢çœŸçš„å˜å˜å¥½åƒä»Šå¤©æ‰“ç‰Œç‰¹åˆ«æ—ºç»ˆäºèµ¢é’±äº†ï¼ï¼ˆä¸è¿‡æ‹¿å»åŠ æ²¹äº†[ä¸¾è½¦] [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8n7eqjby/">
    
    
    
    
    
      
    
    ä»Šå¤©ï¼ˆï¼Ÿå…¶å®æ˜¯æ˜¨å¤©äº†ï¼‰ä¹Ÿè¿‡å¾—å¾ˆå¼€å¿ƒï¼<!-- raw HTML omitted -->æˆ‘ç…çš„è›‹å§å§åŒ…çš„é”…è´´é…ç™½è±¡çš„ç«é¸¡é¢çœŸçš„å˜å˜å¥½åƒ<!-- raw HTML omitted -->ä»Šå¤©æ‰“ç‰Œç‰¹åˆ«æ—ºç»ˆäºèµ¢é’±äº†ï¼ï¼ˆä¸è¿‡æ‹¿å»åŠ æ²¹äº†<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8nf94yDX">è¿™ç§äº‹æƒ…ä¸è¦å•Š[å•èº«ç‹—] - è½¬å‘ @å±±ä¸‹ç¾æœˆæ•™ä¼š:&amp;ensp;å±±ä¸‹ç¾æœˆ#å±±ä¸‹ç¾æœˆæ‰‹æœºåš# 240405.4ã€Œæ™šå®‰ç¾æœˆã€å’Œå®³ç¾é¬¼åšäº†åŒæ ·çš„è¡¨æƒ…çœ¼ç›çœŸå¯æ€•æ˜å¤©æœ‰å¹¸å‡ºæ¼”Venue101èŠ‚...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8nf94ydx/">
    
    
    
    
    
      
    
    è¿™ç§äº‹æƒ…ä¸è¦å•Š<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å±±ä¸‹ç¾æœˆæ•™ä¼š<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_s">https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_s</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8ngmydMR">yamaæ¡‘ä»€ä¹ˆæ—¶å€™æ¥æ‰“æ‰°ä¸€ä¸‹æˆ‘ä»¬å“¦å™œè€å¤´æ³¥å˜­</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8ngmydmr/">
    
    
    
    
    
      
    
    yamaæ¡‘ä»€ä¹ˆæ—¶å€™æ¥æ‰“æ‰°ä¸€ä¸‹æˆ‘ä»¬å“¦å™œè€å¤´æ³¥å˜­  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8omo0c3e">ä¸€æœ¬åŒå¿ƒè¯ä¸€æœ¬å¾ªå¾ªï¼ŒçœŸå¾—åŠ²</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8omo0c3e/">
    
    
    
    
    
      
    
    ä¸€æœ¬åŒå¿ƒè¯ä¸€æœ¬å¾ªå¾ªï¼ŒçœŸå¾—åŠ²  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8ooNov6R">æœˆç»ªçœŸç”œ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8oonov6r/">
    
    
    
    
    
      
    
    æœˆç»ªçœŸç”œ  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O8hMJn0yf">æ­å–œå’²æœˆåŠ å…¥loveitå®¶åº­ï¼ˆæ¯é€±äº”æ¼”å‡ºï¼‰ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o8hmjn0yf/">
    
    
    
    
    
      
    
    æ­å–œå’²æœˆåŠ å…¥loveitå®¶åº­ï¼ˆæ¯é€±äº”æ¼”å‡ºï¼‰ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O8iNKvyMb">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.seventeenjp_mag ins é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o8inkvymb/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.seventeenjp_mag ins &lt;a href=&ldquo;<a href="https://video.weibo.com/show?fid=1034:5019757385023526%22">https://video.weibo.com/show?fid=1034:5019757385023526&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O8jlQdbDs">ç’ƒæœå‡ºæ¼”ã€Œæœ‰é»å¿ƒæ©Ÿåˆä½•å¦¨ã€ï¼ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o8jlqdbds/">
    
    
    
    
    
      
    
    ç’ƒæœå‡ºæ¼”ã€Œæœ‰é»å¿ƒæ©Ÿåˆä½•å¦¨ã€ï¼ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O8jqboHGX">åˆ†äº«å›¾ç‰‡ [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o8jqbohgx/">
    
    
    
    
    
      
    
    åˆ†äº«å›¾ç‰‡ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O8ncNoRhO">æ¸…éº— - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œå¤©è™Ÿæ˜Ÿ é™¢çº¿å‘å¸ƒ åª’ä½“å›¾ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o8ncnorho/">
    
    
    
    
    
      
    
    æ¸…éº—<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->å¤©è™Ÿæ˜Ÿ é™¢çº¿å‘å¸ƒ åª’ä½“å›¾ &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/006z6nxLgy1hog8rwl31lj30xc0m8t9k.jpg%22">https://tvax4.sinaimg.cn/large/006z6nxLgy1hog8rwl31lj30xc0m8t9k.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O8iLwlYvh">æ—¥æœ¬4æœˆé‡æ¦œï¼ˆéå®˜æ–¹ï¼‰å‡ºç‚‰ï¼Œä¸€åŠ›è¾½å‡è‡³ç¬¬ä¸€ï¼Œå¹¿æ¿‘ä¼˜ä¸€å’Œå…³èˆªå¤ªéƒæ™‹å‡å‰10ï¼Œä¸Šé‡çˆ±å’²ç¾è¿›å…¥å‰30#å›´æ£‹#å›´æ£‹ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o8ilwlyvh/">
    
    
    
    
    
      
    
    æ—¥æœ¬4æœˆé‡æ¦œï¼ˆéå®˜æ–¹ï¼‰å‡ºç‚‰ï¼Œä¸€åŠ›è¾½å‡è‡³ç¬¬ä¸€ï¼Œå¹¿æ¿‘ä¼˜ä¸€å’Œå…³èˆªå¤ªéƒæ™‹å‡å‰10ï¼Œä¸Šé‡çˆ±å’²ç¾è¿›å…¥å‰30<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O8jFjnKMn">ä¸¥åŠ¨è™”è¿™ä¸ªæ–¯è’‚èŠ¬æè¡Œä¸ºå¤ªæŠ½è±¡äº†</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o8jfjnkmn/">
    
    
    
    
    
      
    
    ä¸¥åŠ¨è™”è¿™ä¸ªæ–¯è’‚èŠ¬æè¡Œä¸ºå¤ªæŠ½è±¡äº†  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O8jGwawXU">ä»Šå¹´æ—¥æœ¬å¤´è¡”æˆ˜ï¼Œæ‰§ç™½èƒœç‡90%ï¼ˆ9èƒœ1è´Ÿï¼‰å¦å¤–ï¼Œä½©æˆ´çœ¼é•œçš„æ£‹æ‰‹èƒœç‡100%#å›´æ£‹#å›´æ£‹</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o8jgwawxu/">
    
    
    
    
    
      
    
    ä»Šå¹´æ—¥æœ¬å¤´è¡”æˆ˜ï¼Œæ‰§ç™½èƒœç‡90%ï¼ˆ9èƒœ1è´Ÿï¼‰<!-- raw HTML omitted --><!-- raw HTML omitted -->å¦å¤–ï¼Œä½©æˆ´çœ¼é•œçš„æ£‹æ‰‹èƒœç‡100%<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O8jyXdKkr">ä¸¥åŠ¨è™”åšæŒè´¯å½»è½å®ä»€ä¹ˆå±€é¢éƒ½æœ€åä¸€ç§’ä¸‹æ£‹ï¼Œç„¶åç›˜10&#43;å˜åŠç›®èƒœè´Ÿ#å›´æ£‹#å›´æ£‹</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o8jyxdkkr/">
    
    
    
    
    
      
    
    ä¸¥åŠ¨è™”åšæŒè´¯å½»è½å®ä»€ä¹ˆå±€é¢éƒ½æœ€åä¸€ç§’ä¸‹æ£‹ï¼Œç„¶åç›˜10+å˜åŠç›®èƒœè´Ÿ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O8k21dVIO">4æœˆ7æ—¥ ä¸‹åˆ2æ—¶ å¼ˆåŸå›´æ£‹å¹³å°æ–¼ä¹‹è¹vsä»²é‚‘å ‡#å›´æ£‹#å›´æ£‹</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o8k21dvio/">
    
    
    
    
    
      
    
    4æœˆ7æ—¥ ä¸‹åˆ2æ—¶ å¼ˆåŸå›´æ£‹å¹³å°<!-- raw HTML omitted -->æ–¼ä¹‹è¹vsä»²é‚‘å ‡<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O8mRY0n9I">å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šæ—¥æœ¬æ£‹é™¢æˆç«‹å’Œé™¢ç¤¾å¯¹æŠ—æˆ˜â€”â€”æ—¥æœ¬å›´æ£‹ç™¾å¤§å¥ åŸºäºº004ã€‹ #å›´æ£‹# å›´æ£‹ æ—¥æœ¬æ£‹é™¢æˆç«‹å’Œé™¢ç¤¾å¯¹æŠ—æˆ˜â€”â€”æ—¥æœ¬å›´æ£‹ç™¾å¤§å¥ åŸºäºº004 [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o8mry0n9i/">
    
    
    
    
    
      
    
    å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šæ—¥æœ¬æ£‹é™¢æˆç«‹å’Œé™¢ç¤¾å¯¹æŠ—æˆ˜â€”â€”æ—¥æœ¬å›´æ£‹ç™¾å¤§å¥ åŸºäºº004ã€‹ <!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O8munoAuM">å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šæ˜çŸ¥å¤§å­¦å›´æ£‹ç³»å°†è¢«åºŸé™¤ã€‹ #å›´æ£‹# å›´æ£‹ æ˜çŸ¥å¤§å­¦å›´æ£‹ç³»å°†è¢«åºŸé™¤ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o8munoaum/">
    
    
    
    
    
      
    
    å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šæ˜çŸ¥å¤§å­¦å›´æ£‹ç³»å°†è¢«åºŸé™¤ã€‹ <!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a href=&ldquo;<a href="https://weibo.com/">https://weibo.com/</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O8hYZ5Kpl">ä¹…ä¿å²ç»ªé‡Œvia.seventeenjp_mag ins é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o8hyz5kpl/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.seventeenjp_mag ins <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/0">https://h5.sinaimg.cn/upload/2015/0</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O8lMSskb8">ä¹…ä¿å²ç»ªé‡Œå¤©è™Ÿæ˜Ÿ é™¢çº¿å‘å¸ƒ åª’ä½“å›¾ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o8lmsskb8/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->å¤©è™Ÿæ˜Ÿ é™¢çº¿å‘å¸ƒ åª’ä½“å›¾ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z6nxLgy1hog8rwx2zvj">https://tvax1.sinaimg.cn/large/006z6nxLgy1hog8rwx2zvj</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O8lNNcvkL">ä¹…ä¿å²ç»ªé‡Œvia.Venue 101 å®˜X é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o8lnncvkl/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.Venue 101 å®˜X <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/">https://h5.sinaimg.cn/upload/2015/09/25/3/</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O8lQi1KBr">ä¹…ä¿å²ç»ªé‡ŒGEKIÃ—CINEã€å¤©è™Ÿæ˜Ÿã€ åˆæ—¥èˆå°ç›¸å…³è§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o8lqi1kbr/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->GEKIÃ—CINEã€å¤©è™Ÿæ˜Ÿã€ åˆæ—¥èˆå°ç›¸å…³è§†é¢‘ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video controls=&ldquo;controls&rdquo; poster=&ldquo;<a href="https://tvax2.sinaimg.cn/orj480/006z6nxLgy1hog9agyizqj30xw0j20wh.jpg%22">https://tvax2.sinaimg.cn/orj480/006z6nxLgy1hog9agyizqj30xw0j20wh.jpg&quot;</a> style=&ldquo;width: &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/651622023/answer/3455020839">å¼ æ•¬ä¿¡å›ç­”äº†é—®é¢˜: rè¯­è¨€ä¸»æˆåˆ†åˆ†ææ€ä¹ˆç”»å›¾ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-651622023-answer-3455020839/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/651719017/answer/3455023522">å¼ æ•¬ä¿¡å›ç­”äº†é—®é¢˜: r è¯­è¨€å’Œç»Ÿè®¡å­¦æœ‰ä»€ä¹ˆè”ç³»ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-651719017-answer-3455023522/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/651810365/answer/3455456418">å¼ æ•¬ä¿¡å›ç­”äº†é—®é¢˜: æ€ä¹ˆç”¨excelç­›é€‰å‡ºæ¯å¹´365å¤©è¿ç»­æ•°æ®ä¸­æ¯ä¸ªæœˆç¬¬ä¸€å¤©å¯¹åº”çš„æ•°æ®å‘¢ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-651810365-answer-3455456418/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/690796427">é‡å­ä½å‘è¡¨äº†æ–‡ç« : AIGCè¿˜æ˜¯äºŒåˆºçŒ¿ä¼šç©ï¼šæå¨ƒç¤¾åŒºçˆ†ç«ï¼Œæœ‰è„‘æ´å°±èƒ½å½“åŒäººå¤§ä½¬</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-690796427/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/690811646">é‡å­ä½å‘è¡¨äº†æ–‡ç« : è°·æ­Œæ›´æ–°Transformeræ¶æ„ï¼Œæ›´èŠ‚çœè®¡ç®—èµ„æºï¼50%æ€§èƒ½æå‡</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-690811646/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/690812325">é‡å­ä½å‘è¡¨äº†æ–‡ç« : æœ€æ‡‚AIçš„è¯ºå¥–ç»æµå­¦å¾—ä¸»å»ä¸–ï¼Œå¤§æ¨¡å‹å…³é”®æŠ€æœ¯å—ä»–ç ”ç©¶å¯å‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-690812325/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/690813153">é‡å­ä½å‘è¡¨äº†æ–‡ç« : 10ä¸‡ç¾å…ƒè®­å‡ºLlama-2çº§å¤§æ¨¡å‹ï¼å…¨åäººæ‰“é€ æ–°å‹MoEï¼Œè´¾æ‰¬æ¸…SDå‰CEOå›´è§‚</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-690813153/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">Â© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

